ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag evolution art disease medicine science funding

Speaking of Science
The Scientist | Jan 1, 2012 | 2 min read
January 2012's selection of notable quotes
Opinion: Star Trek Medicine
Dean Tantin | Nov 6, 2014 | 3 min read
An apology for basic research
Capsule Reviews
Bob Grant | Nov 1, 2013 | 4 min read
Tracks and Shadows, The Gap, The Cure in the Code, and An Appetite for Wonder
Zebrafish with fluorescent nervous system in green.
Oust the Mouse: A Plan to Reduce Mammal Use in Drug Development
Natalia Mesa, PhD | Mar 15, 2022 | 7 min read
The Scientist spoke to Mount Desert Island Biological Laboratory’s Jim Strickland about the institute’s new MDI Bioscience initiative to perform more drug testing and development in nonmammalian models.
Supplement: Art Caplan
Karen Pallarito | Jan 1, 2008 | 4 min read
Art Caplan By Karen Pallarito A conversation with Penn's renowned ethicist. RELATED ARTICLES Innovative Technology Daniel Skovronsky: Scientist and leader Turning Tobacco into Therapies Biofuel: The Potential Magic Bullet Britton Chance: Still searching for answers Technology Roundup DUSTIN FENSTERMACHER / WONDERFUL MACHINE As a Columbia University philosophy student in the 1970s, Arthur Caplan listened to ongoing discussions about the ethics of
Can Viruses in the Genome Cause Disease?
Katarina Zimmer | Jan 1, 2019 | 10+ min read
Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.
blue-gloved hands pipetting from test tube
What’s Next for Ancient DNA Studies After the Nobel?
Mary Prendergast, The Conversation | Oct 5, 2022 | 4 min read
The award highlights tremendous opportunities for aDNA as well as challenges related to rapid growth, equity, and misinformation.
Decisions, Decisions: NIH's Disease-By-Disease Allocations Draw New Fire
Bruce Agnew | Mar 29, 1998 | 8 min read
'BODY-COUNT BUDGETING'? Rep. Ernest Istook (R-Okla.) is concerned that diseases that cost taxpayers the most money may not be getting a proportionate amount of NIH funds. For the third year in a row, the National Institutes of Health came under fire this month for slighting some diseases and favoring more politically correct ills when it parcels out its research-funding billions. "What this whole thing boils down to," NIH director Harold Varmus recently told a special Institute of Medicine (I
Trumping Science: Part II
Bob Grant | Dec 6, 2016 | 5 min read
As Inauguration Day nears, scientists and science advocates are voicing their unease with the Trump Administration’s potential effects on research.
Evolution, Resisted
Elie Dolgin | Oct 1, 2009 | 10+ min read
Scientists are trying to design the last malaria control agent the world will ever need.

Run a Search

ADVERTISEMENT